The Weight of Evidence

Cortisol and Belly Fat: Why the Blood Test Was Never Going to Settle It

A plain ceramic cup of pale tea on a dark counter at night, steam rising

“Fat accumulated in the abdominal region is associated with elevated cortisol levels. Prolonged stress and depression may contribute to abdominal (visceral) fat accumulation.”

The claim, as it circulates. Anonymized.

Where it circulates

Dr. Eric Berg DC

Drink 1 Cup of This Before Bed for a Smaller Waist

0:50 1,491,774 views on Aug 31, 2026

@98de8e

A viewer describing years of stubborn fat around the waist despite being slim, now read back through a long stretch of high stress and low mood, and thanking the presenter for making the connection.

94 likes 7 replies

“Belly fat is not just a calorie problem. It's a cortisol problem.”

– the host, at 0:02

The adjudicated claim is the commenter's, not the host's.

Peter Attia MD

397 - Endometriosis and adenomyosis: diagnosis, fertility, reproductive aging, & emerging treatments

2:00:26 14,061 views on Aug 31, 2026

@2d0068

A commenter arguing that when someone with endometriosis or adenomyosis eats in a deficit and trains consistently and the weight still does not move, the cause is metabolic adaptation – chronic pain raising cortisol over long periods, suppressing thyroid function and leptin sensitivity, so the body defends its fat stores. The captured text is truncated at this point.

2 likes 1 reply

The claim is from the comment section – not from the episode.

Nothing in this episode supports the claim. The comment originated here, but the claim let go of its source – that is a finding, not a gap.

The adjudicated claim is the commenter's, not the host's.

Jessie Inchauspe / Glucose Revolution

The GLP-1 paradox

1:28 333,242 views on Aug 31, 2026

@3098d1

A commenter arguing the causal order runs the other way: prolonged high cortisol hides GLUT-4 receptors, insulin stays active without being taken up, and fat accumulates as a by-product – so a GLP-1 drug relieves the problem rather than causing it. The captured text is truncated at this point.

1 like 0 replies

The claim is from the comment section – not from the episode.

Nothing in this episode supports the claim. The comment originated here, but the claim let go of its source – that is a finding, not a gap.

The adjudicated claim is the commenter's, not the host's.

A 50-second video opens by telling you that the fat around your middle is not a calorie problem but a cortisol problem. It has been watched 1,491,774 times. The longest of the three episodes where this claim surfaced – a two-hour interview – has been watched 14,061 times. The short outreaches the interview by a factor of 106.

The claim deserves its strongest form before it is tested, because in its strongest form it is not absurd. There is a real disease in which cortisol excess deposits fat around the abdomen, thins the limbs and is reversed when the cortisol is removed. Endocrinologists diagnose it, treat it, and watch the fat retreat. The claim in circulation borrows that mechanism – which is true – and applies it to everyone.

Three of the accounts in this dossier describe the same bedtime tea. One says the waist visibly shrank. One drank it for years and nothing changed. A third asked a doctor for a cortisol test and was refused. All three can be right at once, and the refusal is more defensible than it looks – because a single blood cortisol was never going to settle it either way.

What everyone says

The claim reached us as 4 occurrences across 3 channels in a 28-day window, measured on 3 September 2026. Two of the four sit under the same 50-second video; the other two under a two-hour clinical interview and a short on GLP-1 drugs.

Across the material gathered for this dossier the audience runs about two to one in favour of the claim – 18 supporting comments against 9 opposing – while the literature runs close to even, 16 supporting studies against 11 opposing. That gap is the finding. The claim is more settled in the comment section than it is in the evidence.

Reading the four occurrences together, the pattern is not disagreement about a number. It is a mechanism arriving as a settled fact and then being used as a personal diagnosis. The most-liked comment takes years of stubborn waist fat and a long stressful period and reports that the dots now connect. Nothing in the episode, and nothing in the comment, proposes measuring anything.

There is also a market in that gap, and it is old. In 2004 the U.S. Federal Trade Commission brought an action over the marketing of a beverage sold for abdominal fat loss. The pairing of a drink with a leaner midsection is not new, and it has been the subject of regulatory action before.

What the evidence shows

46 primary sources. The claim is three questions wearing one coat, and each can be answered separately.

Direction of effect

Partial. Evidence: moderate.

The entire answer turns on how cortisol is measured, and the two ways of measuring it point in opposite directions.

Measured as a single circulating value, the association runs from null to inverse. A cross-sectional study of 802 Korean adults found waist circumference and BMI negatively correlated with serum cortisol after adjustment. The Massachusetts Male Ageing Study – 999 men, cross-sectional plus seven-year longitudinal – found weak negative associations with weight, BMI, waist circumference and waist-to-hip ratio. The Paris Prospective Study I, 6,424 men, found cortisol decreasing across rising BMI categories. A case-control study using a 1 µg ACTH challenge found lower basal serum and salivary cortisol in obesity, with inverse correlations against BMI (r = −0.24 to −0.27) and waist circumference (r = −0.27 to −0.34).

Measured as cumulative exposure, the picture reverses. Hair cortisol rose stepwise from eutrophic to overweight to obese categories in ELSA-Brasil (n = 2,499). Perceived stress tracked hair cortisol in a dose-graded way in 1,279 Mexican and Icelandic women: +1.4% per PSS-10 point (95% CI 0.6–2.1), +24.3% comparing top with bottom quintile.

The two findings are not in conflict once you know what sits between them. 11β-HSD1, selectively upregulated in adipose tissue in obesity, regenerates active cortisol locally. Tissue glucocorticoid exposure can therefore be elevated while circulating cortisol is normal or low.

So the claim as stated is defensible for chronic, tissue-level exposure and not defensible for routine blood cortisol. Those are different claims that share a word.

Thresholds

Fails. Evidence: moderate.

The claim commits to no number, and the numbers available in the literature do not survive as boundaries.

The likely source of any dose-graded cortisol figure in this debate is the ELSA-Brasil hair cortisol analysis, which reports a gradual rise across weight categories – but does so by cutting a continuous variable into bands (<40, 40–128, >128 pg/mg) whose outcome is BMI, not visceral fat. Those bins are analytic conveniences. The paper does not claim to have found a threshold.

Three methodological reviews converge against any fixed cortisol cut-off, for three independent reasons: secretion is pulsatile and circadian, so a value is uninterpretable without its sampling time; binding-protein variation, tissue conversion by 11β-HSD and receptor sensitivity decouple the measured number from actual glucocorticoid action; and assay-to-assay and laboratory-to-laboratory variation in reference intervals means “elevated” is partly a decision limit rather than a biological state.

On the adiposity side, the 2026 obesity standards of care endorse waist-based measures with race- and ethnicity-specific BMI thresholds – which is an explicit admission that a single universal abdominal cut-off is a pragmatic convention rather than a biological edge.

Every numeric boundary in this area is an artefact of binning or of measurement convention.

Causal direction

Partial. Evidence: moderate.

At the pathological extreme the direction is well supported by within-patient evidence. In 126 patients with endogenous Cushing’s syndrome, MASLD was present in 62.7% during active hypercortisolism, and the hepatic steatosis index fell after six months of biochemical remission. Cortisol removed, ectopic fat partly reversed – about as close to an intervention as this question allows.

For ordinary psychological stress, the chain breaks at its first link. In 4,467 Danish public-service employees followed over two years, prolonged perceived stress showed no significant association with the level or the trajectory of morning or evening salivary cortisol. An 18-month prospective cohort of 113 women found chronic caregiving stress predicted visceral fat gain only in interaction with impulsive risk-taking, with no main effect of stress alone.

Mendelian randomisation gives partial support, with a caveat that matters: it uses hepatic rather than visceral fat. Anxiety to fatty liver, OR 1.73 (95% CI 1.12–2.67), replicated in 393,229 UK Biobank participants over a median 12.6 years (HR 1.63) with higher MRI liver fat. Major depression to NAFLD, OR 1.233 (95% CI 1.015–1.496) – with BMI mediating 80.7% of the observational association.

And a set of findings pulls the other way. A systematic review of 167 largely prospective studies in children and adolescents found the temporal ordering ran mainly from adiposity to negative affect, not the reverse. A nine-year CHARLS cohort found a higher visceral-adiposity-inflammation index associated with slightly lower incident depression (HR 0.91 per SD). East Asian Mendelian randomisation found genetically higher BMI associated with lower depression and anxiety.

A modest causal contribution of chronic distress to central fat survives. The strong version – stress reliably raises cortisol, which reliably deposits visceral fat – does not.

The adjudication

The canonical quantitative test of the first half of this claim is the 2018 systematic review and random-effects meta-analysis of basal cortisol and metabolic syndrome: 26 observational studies, 21 pooled, 35 comparisons, 11,808 participants. It reports no difference in basal cortisol between people with and without metabolic syndrome – SMD = 0.02, 95% CI −0.11 to 0.14.

That result was itself put to the test, which is why it carries weight here. Heterogeneity was quantified and was high (I² = 83.1%, p < 0.001). Study quality was scored with the Newcastle-Ottawa scale. Publication bias was formally examined with Egger’s and Begg’s tests. And the null is consistent with the direction of the largest single-cohort datasets – 6,424 men in Paris, 999 in Massachusetts, both weakly inverse – and with the ACTH-challenge study showing lower, not higher, basal cortisol in obesity.

As a statement about blood cortisol measured once, “belly fat means high cortisol” is refuted.

What rescues part of the claim is a measurement distinction, not a rhetorical one. A single serum cortisol is a poor index of glucocorticoid exposure for reasons three independent methodological reviews spell out. Measures that integrate exposure over months behave differently – hair cortisol across 2,499 ELSA-Brasil participants, and dose-graded with perceived stress across 1,279 women. And adipose tissue in obesity regenerates active cortisol locally through 11β-HSD1, so tissue exposure can be high while the blood is not.

This is a real qualification rather than a rescue clause: it explains precisely why the blood-test version fails while the tissue-exposure version stays live. It also explains the clinical experience several people describe – that a single cortisol test told them nothing. That is a limitation of the test. It is not a licence to assume the result would have been high.

On causation, the strongest human evidence sits at the pathological extreme, and the audience does not live there. Everyday work stress is exactly where the chain thins: no association with cortisol trajectory across two years in 4,467 employees; visceral fat gain only in interaction with impulsivity in 113 women. The Mendelian randomisation that supports the direction does so through hepatic fat, and its own mediation figure – 80.7% through BMI – suggests the route runs largely through overall weight gain, and therefore through behaviour: appetite, emotional eating, sleep, activity. Not through a direct cortisol-to-adipocyte pathway.

The anecdotal material is symmetrically uninformative and should be read that way. Belly fat appearing during a hard year cannot distinguish stress causing fat from fat, poor sleep, ageing, diet change and low mood moving together. Neither can years of calming tea with no change in the waistline. One opposing comment raises a legitimate physiological point – glucocorticoid disturbance is not unidirectional with respect to body weight. Another raises a legitimate framing point: pairing a bedtime beverage with a lean-abdomen image asserts an effect size that no trial in this dossier supports.

And the practical question – does reducing stress reduce abdominal fat – has not been answered. The only trial-grade probe of that route in this material, a 2×2 factorial randomised trial with 1,627 participants testing an emotion-regulation module for weight-loss maintenance, reports no outcome data in what was available and uses body weight rather than visceral fat or cortisol as its endpoint.

Verdict: partial. The mechanism is real at the extreme and plausible in the middle. The measurement that everyone reaches for cannot see it. And the thing most people actually want to know – whether calming down will flatten the stomach – remains, on this evidence, untested.

The verdict

Verdict: Partially supported

Layer Question Verdict Evidence
Direction of effect Is abdominal fat actually associated with higher cortisol, and does the association behave in a dose-responsive way? Verdict: Partially supported moderate
Thresholds Do the numeric boundaries implied by the claim – an 'elevated' cortisol level, an 'abdominal obesity' cut-off – mark real biological transitions? Verdict: Not supported moderate
Causal direction How much of the stress/depression–abdominal fat association survives designs built to exclude reverse causation? Verdict: Partially supported moderate

Sources

1 Meta-analyses & systematic reviews

  1. The Association Between Affect and Adiposity in Childhood and Adolescence: A Systematic Review. (2026). doi:10.1111/obr.70056 – causal direction, moderate strength · Systematic review of 167 studies (largely prospective/longitudinal) on affect and adiposity in childhood and adolescence, with formal quality appraisal
  2. Fat-brain axis indicated by mutual impacts between body fat and brain phenotypes. (2025). doi:10.1186/s12967-025-07453-8 – causal direction, moderate strength · Bidirectional Mendelian randomisation using six body fat measures, with cross-trait meta-analysis and genetic colocalisation
  3. Yoga as a complementary intervention for polycystic ovary Syndrome management: a systematic review. (2026). doi:10.3389/frph.2026.1753608 – causal direction, low strength · Systematic review of 9 RCTs (no meta-analysis) of yoga in polycystic ovary syndrome
  4. Basal cortisol levels and metabolic syndrome: A systematic review and meta-analysis of observational studies. (2018). doi:10.1016/j.psyneuen.2018.05.023 – direction of effect, high strength · Systematic review and random-effects meta-analysis of 26 observational studies (21 in the pooled analysis, 35 comparisons, 11,808 subjects) on basal cortisol and metabolic syndrome

2 Randomized controlled trials

  1. Effect of Multi-Antioxidant Supplement on Lipid Profile, Occupational Fatigue, Work Stress, and Hair Cortisol in Administrative Workers with and Without Obesity: A Quasi-Experimental Pilot Study. (2026). doi:10.3390/healthcare14091166 – causal direction, low strength · Quasi-experimental (non-randomised) pilot trial, 30 days, n=22 (17 supplement vs 5 placebo), with hair cortisol as outcome in workers with and without obesity
  2. A Digital Toolkit for Weight Loss Maintenance in European Adults (NoHoW): 2×2 Factorial Randomized Controlled Trial. (2026). doi:10.2196/69634 – causal direction, moderate strength · Large 2×2 factorial, single-blind randomised controlled trial (n=1627, 3 European centres, 18-month weight-loss maintenance)
  3. Multicomponent Nutritional Approach (NutrirCom) and Its Effects on Anthropometric, Metabolic, and Psychoemotional Outcomes in Women with Obesity: A Three-Arm Randomized Clinical Trial. (2026). doi:10.3390/nu18030414 – causal direction, low strength · Three-arm, parallel, open-label randomised clinical trial (n=89 women with obesity, primary care)

3 Cohort studies

  1. Understanding the somatic consequences of depression: biological mechanisms and the role of depression symptom profile. (2013). doi:10.1186/1741-7015-11-129 – direction of effect, low strength · Narrative review synthesising cohort and case-control evidence on depression, HPA-axis function and metabolic outcomes
  2. Metabolic dysfunction-associated steatotic liver disease in Cushing's syndrome: prevalence, determinants, and changes after remission. (2026). doi:10.3389/fendo.2026.1790066 – causal direction, low strength · Retrospective cohort of 126 patients with endogenous Cushing's syndrome, with within-patient before/after comparison at six months of biochemical remission
  3. From Mind to Liver: Exploring the Causal Relationship Between Anxiety Disorders and Non-Alcoholic Fatty Liver Disease Through Mendelian Randomization and UK Biobank Validation. (2025). doi:10.2147/jmdh.s546590 – causal direction, moderate strength · Mendelian randomisation plus prospective cohort validation (UK Biobank, n=393,229, median 12.6 years follow-up) with imaging endpoint
  4. Association of CTI and its obesity-related derivatives with incident depression among middle-aged and older adults across CKM stages 0-4: a nationwide prospective cohort study and external clinical validation. (2026). doi:10.3389/fendo.2026.1849662 – causal direction, moderate strength · Nationwide prospective cohort (CHARLS, n=3,130, 9-year median follow-up) with machine-learning covariate selection, Cox models, restricted cubic splines and external clinical validation (n=350)
  5. Similar Adiposity Improvements but Different Eating Behavior and Mental Health Responses in Men and Women: A 12-Week Exploratory Study. (2026). doi:10.3390/nu18111809 – causal direction, low strength · 12-week uncontrolled exploratory prospective longitudinal dietary intervention (19 women, 9 men) with sex-stratified analysis
  6. Chronic Stress and Impulsive Risk-Taking Predict Increases in Visceral Fat over 18 Months. (2018). doi:10.1002/oby.22150 – causal direction, moderate strength · Prospective cohort with 18-month lag (n=113 women; high-stress caregivers vs. controls; visceral fat by bioelectrical impedance)
  7. Cortisol levels and measures of body composition in middle-aged and older men. (2007). doi:10.1111/j.1365-2265.2007.02837.x – direction of effect, moderate strength · Population-based cohort with cross-sectional and longitudinal (7-year) analyses, 999 men aged 40–79 (Massachusetts Male Ageing Study)
  8. The relationship of blood pressure with glucose, insulin, heart rate, free fatty acids and plasma cortisol levels according to degree of obesity in middle-aged men. (1996). doi:10.1097/00004872-199602000-00012 – direction of effect, low strength · Cross-sectional analysis of 6,424 middle-aged men from the Paris Prospective Study I (single morning plasma cortisol)
  9. Hair cortisol levels are associated with overweight and obesity in the ELSA-Brasil cohort. (2024). doi:10.3389/fendo.2024.1361715 – direction of effect, low strength · Cross-sectional analysis of 2,499 participants in the ELSA-Brasil cohort (hair cortisol as a long-term HPA marker, categorised into arbitrary tertile-like bands)
  10. Prolonged perceived stress and saliva cortisol in a large cohort of Danish public service employees: cross-sectional and longitudinal associations. (2017). doi:10.1007/s00420-017-1241-z – causal direction, moderate strength · Large occupational cohort (n=4467, follow-up n=3217) with cross-sectional and longitudinal analyses of perceived stress and morning/evening salivary cortisol
  11. Perceived stress and hair cortisol concentration in a study of Mexican and Icelandic women. (2022). doi:10.1371/journal.pgph.0000571 – direction of effect, moderate strength · Cross-sectional analysis pooling two cohorts (881 Mexican and 398 Icelandic women) linking Perceived Stress Scale scores to hair cortisol concentration measured by LC-MS/MS

4 Cross-sectional studies

  1. Work engagement and its association with obesity and lifestyle factors in a large working population: a sex-stratified analysis. (2026). doi:10.3934/publichealth.2026017 – direction of effect, low strength · Very large cross-sectional occupational study (n = 111,612) with logistic regression and mediation analysis
  2. Relationship of body composition with cortisol and dehydroepiandrosterone sulfate levels in Korean men and women. (2026). doi:10.1177/03000605251413389 – direction of effect, low strength · Cross-sectional analysis of 802 Korean adults with partial correlation and multiple logistic regression on single-timepoint serum cortisol and DHEA-S
  3. Effects of Lifestyle, Diet, and Body Composition on Free Testosterone and Cortisol Levels in Young Men. (2025). doi:10.3390/nu17233772 – direction of effect, low strength · Cross-sectional observational study of 40 healthy young men with body composition, single morning serum cortisol and validated stress/sleep questionnaires
  4. Cortisol Secretion in Obesity Revisited: Lower Basal Serum and Salivary Cortisol with Diminished Cortisol Response to the Low Dose ACTH Challenge. (2025). doi:10.1159/000543449 – direction of effect, moderate strength · Cross-sectional case–control study with 1 µg ACTH stimulation test (60 healthy adults with obesity vs 54 lean controls)
  5. Emotional eating behaviour and obesity in adolescents: a cross-sectional survey in Taizhou, China. (2026). doi:10.1186/s13690-026-01953-9 – direction of effect, low strength · School-based cross-sectional survey (n=881 adolescents) with linear, multinomial and binary logistic regression
  6. Inflammatory and neuroendocrine biomarkers associated with mental health symptoms across body mass index categories: a cross-sectional machine learning analysis. (2026). doi:10.3389/fimmu.2026.1800205 – direction of effect, low strength · Cross-sectional biomarker study (n=251 adults) with Random Forest machine-learning variable-importance ranking
  7. Investigating the visceral adiposity-major depressive disorder link: a cross-sectional NHANES 2011-2014 analysis and Mendelian randomization study. (2025). doi:10.1007/s40519-025-01777-6 – causal direction, moderate strength · Cross-sectional NHANES 2011-2014 analysis (weighted multivariable logistic regression, restricted cubic splines) plus Mendelian randomisation for directionality
  8. Visceral obesity and insulin resistance are associated with plasma aldosterone levels in women. (1999). doi:10.1002/j.1550-8528.1999.tb00418.x – direction of effect, low strength · Small cross-sectional study with CT-measured visceral fat (28 women, 27 men) plus an uncontrolled weight-loss intervention arm
  9. Genetic factors, perceived chronic stress, and the free cortisol response to awakening. (2000). doi:10.1016/s0306-4530(00)00021-4 – direction of effect, low strength · Cross-sectional twin study (52 monozygotic and 52 dizygotic pairs) with repeated salivary cortisol sampling on two consecutive days plus questionnaire measures of chronic stress

5 Mechanistic evidence

  1. "Feeding the Rhythm"-Effects of Food and Nutrients on Daily Cortisol Secretion: From Molecular Mechanisms to Clinical Impact. (2025). doi:10.3390/ijms262211230 – causal direction, low strength · Narrative review of feeding, circadian rhythm and cortisol secretion
  2. The Functional and Clinical Significance of the 24-Hour Rhythm of Circulating Glucocorticoids. (2017). doi:10.1210/er.2015-1080 – thresholds, low strength · Narrative endocrine review of the 24-hour glucocorticoid rhythm and its clinical significance
  3. The roles, mechanisms, and therapeutic implications of glucocorticoids in glucose and lipid metabolism. (2026). doi:10.1016/j.mmr.2026.100037 – causal direction, low strength · Narrative mechanistic review of glucocorticoid physiology
  4. 11β-hydroxysteroid dehydrogenases: intracellular gate-keepers of tissue glucocorticoid action. (2013). doi:10.1152/physrev.00020.2012 – causal direction, moderate strength · Comprehensive physiological review synthesising human tissue studies, rodent knockout/overexpression models and human inhibitor trials
  5. The multiple roles of life stress in metabolic disorders. (2023). doi:10.1038/s41574-022-00746-8 – causal direction, moderate strength · Narrative review integrating rodent experimental evidence and human epidemiology on stress and metabolic disease
  6. Association Between Body Mass Index and Depression/Anxiety in an East Asian Population: A Mendelian Randomization Study. (2026). doi:10.1002/kjm2.70161 – causal direction, moderate strength · Two-sample Mendelian randomisation (13 and 17 SNPs; 107,191 Taiwanese adults, 4855 cases)
  7. Triangulating the link between depression and liver disease: An integrative analysis of genetic, observational, and research trend data. (2026). doi:10.1016/j.cpnec.2026.100346 – causal direction, moderate strength · Triangulation: two-sample Mendelian randomisation plus NHANES 2007–2020 survey-weighted regression with formal causal mediation analysis
  8. Pathophysiology of depression and anxiety in metabolic dysfunction-associated steatotic liver disease. (2025). doi:10.4291/wjgp.v16.i4.111029 – causal direction, low strength · Narrative pathophysiological review of mechanisms linking steatotic liver disease with depression/anxiety
  9. Mendelian randomization: genetic anchors for causal inference in epidemiological studies. (2014). doi:10.1093/hmg/ddu328 – causal direction, low strength · Methodological review of Mendelian randomisation
  10. Do stress reactions cause abdominal obesity and comorbidities? (2001). doi:10.1046/j.1467-789x.2001.00027.x – causal direction, low strength · Narrative review/overview of population, clinical, cellular and animal evidence (no quantitative synthesis)

6 Other primary sources

  1. Emotional Eating and Abdominal Obesity: A Narrative Review of the Potential Mechanisms Underlying Their Relationship and Emerging Interventions for Their Management. (2026). doi:10.3390/nu18111767 – causal direction, low strength · Narrative (non-systematic) review of literature 2015-2025, PubMed and Google Scholar
  2. Serum Cortisol and Cardiovascular Disease Risk - A Potential Biomarker. (2025). doi:10.2174/011573403x328499241106064553 – direction of effect, low strength · Narrative review of serum cortisol as a cardiovascular risk biomarker
  3. The Role of Cortisol and Dehydroepiandrosterone in Obesity, Pain, and Aging. (2025). doi:10.3390/diseases13020042 – direction of effect, low strength · Narrative review of cortisol/DHEA(S) in obesity, pain and aging
  4. Current Challenges and Future Directions in the Assessment of Glucocorticoid Status. (2024). doi:10.1210/endrev/bnae016 – thresholds, low strength · Narrative/state-of-the-art endocrine review of methods for assessing glucocorticoid status
  5. The Treatment of Cushing's Disease. (2015). doi:10.1210/er.2013-1048 – causal direction, low strength · Narrative review of treatment options in Cushing's disease
  6. Evaluation of adrenal incidentalomas: Current approaches, caveats, and unexplored issues. (2026). doi:10.4329/wjr.v18.i4.119833 – causal direction, low strength · Narrative/clinical review of adrenal incidentaloma evaluation
  7. Impact of Variation between Assays and Reference Intervals in the Diagnosis of Endocrine Disorders. (2023). doi:10.3390/diagnostics13223453 – thresholds, moderate strength · Methodological review of assay variability and reference intervals in endocrine testing
  8. Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults: Standards of Care in Overweight and Obesity-2026. (2026). doi:10.1136/bmjdrc-2026-006247 – thresholds, moderate strength · Evidence-based clinical practice guideline (ADA Obesity Association standards of care)
  9. Cushing Syndrome: A Review. (2023). doi:10.1001/jama.2023.11305 – causal direction, high strength · Narrative clinical review (JAMA), incluindo epidemiologia da sindrome de Cushing endogena

Documentary record

  • U.S. Federal Trade Commission – acao regulatoria: FTC File No. 042-3057 · Civil Action No. CV04-8190 DSF (JTLx), U.S. District Court, Central District of California (Oct 5, 2004)